泽璟制药-U
(688266)
| 流通市值：280.33亿 | | | 总市值：280.33亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,070,253,178.01 | 2,117,480,591.46 | 2,102,866,553.5 | 2,153,678,920.77 |
| 交易性金融资产 | 16,202,207.73 | 33,972,692.65 | 33,697,125.44 | 40,500,717.3 |
| 应收票据及应收账款 | 178,322,601.4 | 175,399,720.05 | 137,742,821.24 | 143,628,405.6 |
| 其中：应收票据 | 33,570 | - | 324,131.6 | 324,131.6 |
| 应收账款 | 178,289,031.4 | 175,399,720.05 | 137,418,689.64 | 143,304,274 |
| 预付款项 | 47,610,994.58 | 47,256,101.22 | 40,584,719.96 | 41,281,442.35 |
| 其他应收款合计 | 10,473,035.7 | 9,741,045.61 | 9,621,709.34 | 9,380,983.92 |
| 存货 | 174,370,083.91 | 164,215,169.54 | 167,491,327.54 | 182,861,135.29 |
| 其他流动资产 | 8,691,244.3 | 3,563,748.87 | 4,556,024.47 | 4,567,204.57 |
| 流动资产合计 | 2,505,923,345.63 | 2,551,629,069.4 | 2,496,560,281.49 | 2,575,898,809.8 |
| 非流动资产: | | | | |
| 固定资产 | 189,112,784.72 | 194,457,164.6 | 199,387,144.12 | 205,300,520.51 |
| 在建工程 | 248,998,132.79 | 152,531,961.67 | 127,053,501.11 | 123,471,414.28 |
| 使用权资产 | 18,689,490.38 | 19,141,912.99 | 25,167,656.2 | 34,655,845.75 |
| 无形资产 | 35,478,371.96 | 40,178,060.57 | 45,097,791.62 | 50,010,842.64 |
| 长期待摊费用 | 7,299,204.28 | 8,739,853.31 | 10,231,304.37 | 11,393,549.07 |
| 其他非流动资产 | 7,876,108.6 | 32,525,329.5 | 14,326,202 | 3,883,301.93 |
| 非流动资产合计 | 507,454,092.73 | 447,574,282.64 | 421,263,599.42 | 428,715,474.18 |
| 资产总计 | 3,013,377,438.36 | 2,999,203,352.04 | 2,917,823,880.91 | 3,004,614,283.98 |
| 流动负债: | | | | |
| 短期借款 | 966,944,810.81 | 976,363,228.04 | 881,534,044.49 | 951,861,764.88 |
| 应付票据及应付账款 | 223,894,825.33 | 195,242,184.05 | 201,586,659.57 | 197,103,446.9 |
| 其中：应付票据 | 20,512,200 | 17,637,650 | 18,067,154.8 | 10,208,204.8 |
| 应付账款 | 203,382,625.33 | 177,604,534.05 | 183,519,504.77 | 186,895,242.1 |
| 预收款项 | - | - | - | 15,290.52 |
| 合同负债 | 1,697,868.2 | 524,982.09 | 273,558.2 | - |
| 应付职工薪酬 | 62,431,883.94 | 66,171,395.63 | 46,444,944.33 | 68,504,827.25 |
| 应交税费 | 41,700,151.4 | 35,088,475.5 | 36,620,178.49 | 33,445,688.39 |
| 其他应付款合计 | 35,470,230.93 | 45,457,064.72 | 109,082,718.93 | 106,347,910.54 |
| 一年内到期的非流动负债 | 22,664,794.7 | 23,376,316.37 | 49,939,460.63 | 16,166,597.35 |
| 其他流动负债 | 50,936.04 | - | - | - |
| 流动负债合计 | 1,354,855,501.35 | 1,342,223,646.4 | 1,325,481,564.64 | 1,373,445,525.83 |
| 非流动负债: | | | | |
| 长期借款 | 125,699,999.96 | 125,699,999.96 | 59,812,578.75 | 44,350,969.43 |
| 租赁负债 | 10,358,629.52 | 13,140,162.19 | 13,073,221.81 | 26,861,235.3 |
| 递延收益 | 2,872,822.51 | 7,661,566.09 | 8,019,159.7 | 9,201,753.31 |
| 递延所得税负债 | 2,652,079.77 | 3,673,860.67 | 4,688,624.66 | 5,701,419.8 |
| 其他非流动负债 | 367,924,529.37 | 330,188,680.29 | 283,018,868.95 | 292,452,831.19 |
| 非流动负债合计 | 509,508,061.13 | 480,364,269.2 | 368,612,453.87 | 378,568,209.03 |
| 负债合计 | 1,864,363,562.48 | 1,822,587,915.6 | 1,694,094,018.51 | 1,752,013,734.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 264,708,186 | 264,708,186 | 264,708,186 | 264,708,186 |
| 资本公积 | 3,109,476,536.44 | 3,116,344,427.97 | 3,120,645,068.74 | 3,120,366,607.65 |
| 其他综合收益 | -15,012,183.49 | -14,891,154.47 | -14,335,489.01 | -14,474,378.1 |
| 未分配利润 | -2,210,158,663.07 | -2,189,546,023.06 | -2,145,004,719.2 | -2,116,742,484.07 |
| 归属于母公司股东权益合计 | 1,149,013,875.88 | 1,176,615,436.44 | 1,226,013,046.53 | 1,253,857,931.48 |
| 少数股东权益 | - | - | -2,283,184.13 | -1,257,382.36 |
| 股东权益合计 | 1,149,013,875.88 | 1,176,615,436.44 | 1,223,729,862.4 | 1,252,600,549.12 |
| 负债和股东权益合计 | 3,013,377,438.36 | 2,999,203,352.04 | 2,917,823,880.91 | 3,004,614,283.98 |
| 公告日期 | 2025-10-31 | 2025-08-23 | 2025-04-19 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |